昭衍新药:昭衍新药2022年度非经营性资金占用及其他关联资金往来情况的专项说明2023-03-31
2022
2022 2022 2022 2022
2022
( ) ( )
- - - - -
/ / / - - - - - / /
- - - - -
/ / / - - - - - / /
/ / / - - - - - / /
2022 2022 2022 2022
2022
( ) ( )
1,785.67 4,127.59 - 4,680.39 1,232.87
- 41.44 - - 41.44
Staidson - 2,119.34 - 1,181.69 937.65
Biopharma
Inc.
- 15.94 - 14.44 1.50
/ / / 1,785.67 6,304.31 - 5,876.52 2,213.46 / /
1 3
2022 2022 2022 2022 2022
( ) ( )
553.98 - - 150.00 403.98
41.35 - - 41.35 -
13.96 - - 13.96 -
6,500.00 1.00 - 6,501.00 -
800.00 200.00 - - 1,000.00
1,719.40 - - 1,719.40 -
48.32 101.40 - 49.40 100.32
- 94.76 - - 94.76
/ / / 9,677.01 397.16 - 8,475.11 1,599.06 / /
2 3